TSX:HHL Holdings Information

TSX:HHL is an equity ETF with a total of 24 individual holdings. The top holdings are Johnson & Johnson stock at 5.76%, Merck & Co. at 5.63%, Novartis AG ADR at 5.54%, Bristol-Myers Squibb Company at 5.52%, and AstraZeneca at 5.33%.

Total Holdings

Top 10 Percentage

52.81%

Asset Class

Equity

ETF Category

Health Care

Assets

1.61B

PE Ratio

21.81

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	5.76%	330,861
2	MRK	Merck & Co., Inc.	5.63%	667,001
3	NVSN.MX	Novartis AG ADR	5.54%	486,427
4	BMY	Bristol-Myers Squibb Company	5.52%	1,309,608
5	AZN	AstraZeneca PLC	5.33%	750,245
6	MDT	Medtronic plc	5.23%	662,854
7	AMGN	Amgen Inc.	5.15%	196,700
8	ELV	Elevance Health, Inc.	4.96%	187,303
9	TMO	Thermo Fisher Scientific Inc.	4.91%	110,745
10	SYK	Stryker Corporation	4.79%	169,125
11	REGN	Regeneron Pharmaceuticals, Inc.	4.78%	84,127
12	ABBV	AbbVie Inc.	4.74%	277,319
13	LLY	Eli Lilly and Company	4.73%	59,577
14	DHR	Danaher Corporation	4.67%	278,534
15	ABT	Abbott Laboratories	4.56%	545,382
16	UNH	UnitedHealth Group Incorporated	4.50%	204,874
17	BSX	Boston Scientific Corporation	4.40%	614,792
18	ISRG	Intuitive Surgical, Inc.	4.31%	111,671
19	A	Agilent Technologies, Inc.	4.30%	419,714
20	ZTS	Zoetis Inc.	4.09%	428,328
21	n/a	Cash And Other Net Assets And Liabilities	1.00%	n/a
22	n/a	Harvest Canadian T Bill Etp	0.91%	323,817
23	n/a	Foreign Currency Forwards	0.62%	n/a
24	n/a	Written Call Options	-0.43%	n/a

As of Jan 31, 2026